The purpose of this study is to determine if 600 mg of rifaximin, taken once a day for 14
days by healthy subjects, is safe and effective for the prevention of travellers' diarrhea
compared to placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.